A Real-World Registry to Investigate the Performance of LenSx® Laser in Chinese Patients

NCT ID: NCT02396719

Last Updated: 2016-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1541 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-03-31

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the performance of LenSx® Laser in femtosecond laser-assisted cataract surgery (FLACS) in real-world medical practice in Chinese patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All subjects will undergo FLACS using the LenSx® Laser system. The recommended postoperative visits will follow the current standard of care in China.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataracts

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LenSx

Phacoemulsification cataract surgery in at least 1 eye using LenSx® Laser technology

LenSx® Laser

Intervention Type DEVICE

Used for cornea incision, capsulotomy and lens fragmentation during cataract surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LenSx® Laser

Used for cornea incision, capsulotomy and lens fragmentation during cataract surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chinese;
* Will undergo LenSx® Laser-assisted cataract surgery and phacoemulsification in at least one eye;
* Must sign written informed consent;

Exclusion Criteria

* Contraindications listed in LenSx® Laser System Operator's Manual;
* Pregnant, nursing, or planning a pregnancy;
* Concurrent enrollment in another investigational drug and/or device study or participation in such a study within 30 days prior to surgery day;
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zuojun Gao, Medical Affairs Director

Role: STUDY_DIRECTOR

Alcon China

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alcon China Ophthalmic Product Co., Ltd.

Beijing, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CTO130-P001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Laser Treatment of the Crystalline Lens
NCT01001117 UNKNOWN PHASE2/PHASE3